Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKinsey
Teva
Covington
Farmers Insurance
Argus Health
Chubb
Dow
QuintilesIMS

Generated: January 19, 2018

DrugPatentWatch Database Preview

RAMIPRIL Drug Profile

« Back to Dashboard

Which patents cover Ramipril, and when can generic versions of Ramipril launch?

Ramipril is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Apotex, Aurobindo Pharma Ltd, Cipla, Dr Reddys Labs Ltd, Invagen Pharms, Lupin, Ranbaxy Labs Ltd, Sandoz, Teva Pharms, Watson Labs, West-ward Pharms Int, Zydus Pharms Usa, Apotex Inc, Mylan Pharms Inc, and Zydus Pharms Usa Inc. and is included in seventeen NDAs.

The generic ingredient in RAMIPRIL is ramipril. There are nineteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the ramipril profile page.

US Patents and Regulatory Information for RAMIPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms RAMIPRIL ramipril CAPSULE;ORAL 077470-003 Jun 18, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin RAMIPRIL ramipril CAPSULE;ORAL 077626-004 Jun 9, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int RAMIPRIL ramipril CAPSULE;ORAL 077900-003 Jun 18, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc RAMIPRIL ramipril TABLET;ORAL 090650-002 Jun 30, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs RAMIPRIL ramipril CAPSULE;ORAL 076549-003 Oct 24, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int RAMIPRIL ramipril CAPSULE;ORAL 077900-004 Jun 18, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc RAMIPRIL ramipril TABLET;ORAL 091069-001 Dec 2, 2015 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc RAMIPRIL ramipril TABLET;ORAL 090650-003 Jun 30, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Invagen Pharms RAMIPRIL ramipril CAPSULE;ORAL 078745-004 Jun 18, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ranbaxy Labs Ltd RAMIPRIL ramipril CAPSULE;ORAL 078849-001 Mar 6, 2009 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
Julphar
Citi
AstraZeneca
Moodys
Cantor Fitzgerald
US Department of Justice
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot